The effect of cholestasis on rewarding and exploratory behaviors induced by opioidergic and dopaminergic agents in mice

Archives of Iranian Medicine

Volumn 15, Issue 10, 2012, Pages 617-624

  Ebrahimi ghiri, Mohaddeseh ^a   Nasehi, Mohammad ^b   Rostami, Parvin ^a   Mohseni Kouchesfehani, Homa ^a   Zarrindast, Mohammad Reza ^c,d,e,f  

^a KHARAZMI UNIVERSITY   (Iran)

^b ISLAMIC AZAD UNIVERSITY   (Iran)

^c INSTITUTE FOR COGNITIVE SCIENCE STUDIES ICSS   (Iran)

^d TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^f INSTITUTE FOR RESEARCH IN FUNDAMENTAL SCIENCES IPM   (Iran)

Author keywords

Cholestasis; Conditioned place preference; Dopaminergic agents; Exploratory behaviors morphine

Indexed keywords

2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; DOPAMINE RECEPTOR STIMULATING AGENT; MORPHINE; NALOXONE; OPIATE AGONIST; QUINPIROLE; SULPIRIDE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AVERSION; BILE DUCT LIGATION; CHOLESTASIS; CONDITIONING; CONTROLLED STUDY; DEFECATION; DISEASE ASSOCIATION; DOWN REGULATION; DRUG EFFECT; EXPLORATORY BEHAVIOR; GROOMING; LATENT PERIOD; LOCOMOTION; MALE; MOUSE; NONHUMAN; OUTCOME ASSESSMENT; PLACE PREFERENCE; REARING; REWARD; SHAM PROCEDURE;

2,3,4,5-TETRAHYDRO-7,8-DIHYDROXY-1-PHENYL-1H-3-BENZAZEPINE; ANALGESICS, OPIOID; ANALYSIS OF VARIANCE; ANIMALS; BEHAVIOR, ANIMAL; BENZAZEPINES; CHOLESTASIS; DOPAMINE AGENTS; EXPLORATORY BEHAVIOR; MALE; MICE; MORPHINE; NALOXONE; NARCOTIC ANTAGONISTS; QUINPIROLE; REWARD; SULPIRIDE;

EID: 84867253320     PISSN: 10292977     EISSN: 17353947     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Haber SN, Knutson B. The reward circuit: linking primate anatomy and human imaging. Neuropsychopharmacology. 2010; 35: 4-26.
2. Zarrindast MR, Ebrahimi-Ghiri M, Rostami P, Rezayof A. Repeated pre-exposure to morphine into the ventral pallidum enhances morphine-induced place preference: involvement of dopaminergic and opioidergic mechanisms. Behav Brain Res. 2007; 181: 35-41.
3. Zarrindast MR, Moghimi M, Rostami P, Rezayof A. Histaminergic receptors of medial septum and conditioned place preference: D1 dopamine receptor mechanism Brain Res. 2006; 1109: 108-116.
4. Sealfon SC, Olanow CW. Dopamine receptors: from structure to behavior. Trends Neurosci. 2000; 23(suppl 10): S34-40.
5. Kebabian JW, Calne DB. Multiple receptors for dopamine. Nature. 1979; 277: 93-96.
6. Wise RA, Bozarth MA. A psychomotor stimulant theory of addiction. Psychol Rev. 1987; 94: 469-492.
7. Rezayof A, Golhasani-Keshtan F, Haeri-Rohani A, Zarrindast MR. Morphine-induced place preference: involvement of the central amygdala NMDA receptors. Brain Res. 2007; 1133: 34-41.
8. Manzanedo C, Aguilar MA, Rodriguez-Arias M, Minarro J. Effects of dopamine antagonists with different receptor blockade profiles on morphine-induced place preference in male mice. Behav Brain Res. 2001; 121: 189-197.
9. Kountouras J, Billing BH, Scheuer PJ. Prolonged bile duct obstruction: a new experimental model for cirrhosis in the rat Br J Exp Pathol. 1984; 65: 305-311.
10. Swain MG, Rothman RB, Xu H, Vergalla J, Bergasa NV, Jones EA Endogenous opioids accumulate in plasma in a rat model of acute cholestasis. Gastroenterology. 1992; 103: 630-635.
11. Ghafourifar P, Dehpour AR, Akbarloo N. Inhibition by L-NA, a nitric oxide synthase inhibitor, of naloxone-precipitated withdrawal signs in a mouse model of cholestasis. Life Sci. 1997; 60: PL265-270.
12. Zarrindast MR, Habibi M, Borzabadi S, Fazli-Tabaei S, Hossein Yahyavi S, Rostamin P. The effects of dopamine receptor agents on naloxone-induced jumping behaviour in morphine-dependent mice. Eur J Pharmacol. 2002; 451: 287-293.
13. Zarrindast MR, Mousa-Ahmadi E. Effects of GABAergic system on naloxone-induced jumping in morphine-dependent mice. Eur J Pharmacol. 1999; 381: 129-133.
14. Bergasa NV, Rothman RB, Vergalla J, Xu H, Swain MG, Jones EA. Central mu-opioid receptors are down-regulated in a rat model of cholestasis. J Hepatol. 1992; 15: 220-224.
15. Muranyi M, Radak Z. Pain and opioids. Orv Hetil. 2008; 149: 2363-2370.
16. Bardo MT, Bevins RA. Conditioned place preference: what does it add to our preclinical understanding of drug reward? Psychopharma-cology (Berl). 2000; 153: 31-43.
17. Sahraei H, Etemadi L, Rostami P, Pourmotabbed A, Zarrindast MR Shams J, et al. GABAB receptors within the ventral tegmental area are involved in the expression and acquisition of morphine-induced place preference in morphine-sensitized rats. Pharmacol Biochem Behav. 2009; 91: 409-416.
18. Bergasa NV, Alling DW, Vergalla J, Jones EA. Cholestasis in the male rat is associated with naloxone-reversible antinociception J Hepatol. 1994; 20: 85-90.
19. Rastegar H, Homayoun H, Afifi M, Rezayat M, Dehpour AR. Modulation of cholestasis-induced antinociception by CCK receptor agonists and antagonists. Eur Neuropsychopharmacol. 2002; 12: 111-118.
20. Zarrindast MR, Sattari-Naeini M, Khalilzadeh A. Involvement of glucose and ATP-sensitive potassium (K+) channels on morphine-induced conditioned place preference. Eur J Pharmacol. 2007; 573: 133-138.
21. Rezayof A, Sardari M, Zarrindast MR, Nayer-Nouri T. Functional interaction between morphine and central amygdala cannabinoid CB1 receptors in the acquisition and expression of conditioned place preference. Behav Brain Res. 2011; 220: 1-8.
22. Karami M, Karimian Azimi M, Zarrindast MR, Khalaji Z. Verifying of participation of nitric oxide in morphine place conditioning in the rat medial septum using nicotinamide adenine dinucleotide phos-phate-diaphorase (NADPH-d). Iran Biomed J. 2011; 14: 150-157.
23. Boissier JR, Simon P. The exploration reaction in the mouse. Preliminary note. Therapie. 1962; 17: 1225-1232.
24. Zarrindast MR, Nasehi M, Piri M, Bina P. Anxiety-like behavior induced by histaminergic agents can be prevented by cannabinoidergic WIN55,212-2 injected into the dorsal hippocampus in mice. Pharmacol Biochem Behav. 2010; 94: 387-396.
25. Gholipour T, Riazi K, Noorian AR, Jannati A, Honar H, Doratotaj B, et al. Seizure susceptibility alteration following reversible cholestasis in mice: Modulation by opioids and nitric oxide. Eur J Pharmacol. 2008; 580: 322-328.
26. Demehri S, Samini M, Namiranian K, Rastegar H, Mehr SE, Homay-oun H, et al. Alpha 2-adrenoceptor and NO mediate the opioid sub-sensitivity in isolated tissues of cholestatic animals. Auton Autacoid Pharmacol. 2003; 23: 201-207.
27. Seki E, de Minicis S, Inokuchi S, Taura K, Miyai K, van Rooijen N, et al. CCR2 promotes hepatic fibrosis in mice. Hepatology. 2009; 50: 185-197.
28. Patsenker E, Popov Y, Stickel F, Schneider V, Ledermann M, Sagesser H, et al. Pharmacological inhibition of integrin alphavbeta3 aggravates experimental liver fibrosis and suppresses hepatic angiogenesis. Hepatology. 2009; 50: 1501-1511.
29. Glaser S, DeMorrow S, Francis H, Ueno Y, Gaudio E, Vaculin S, et al. Progesterone stimulates the proliferation of female and male cholan-giocytes via autocrine/paracrine mechanisms. Am J Physiol Gastroin-test Liver Physiol. 2008; 295: G124-G136.
30. Marzioni M, Fava G, Benedetti A. Nervous and Neuroendocrine regulation of the pathophysiology of cholestasis and of biliary carcinogenesis. World J Gastroenterol. 2006; 12: 3471-3480.
31. Nicoll J, Axiotis CA, Bergasa NV. The delta opioid receptor 1 is expressed by proliferating bile ductules in rats with cholestasis: implications for the study of liver regeneration and malignant transformation of biliary epithelium Med Hypotheses. 2005; 65: 1099-1105.
32. Banks WA, Kastin AJ. Peptide transport systems for opiates across the blood-brain barrier. Am J Physiol. 1990; 259: E1-E10.
33. Nahavandi A, Mani AR, Homayounfar H, Akbari MR, Dehpour AR. The role of the interaction between endogenous opioids and nitric oxide in the pathophysiology of ethanol-induced gastric damage in cholestatic rats. Fundam Clin Pharmacol. 2001; 15: 181-187.
34. Kivastik T, Rutkauskaite J, Zharkovsky A. Nitric oxide synthesis inhibition attenuates morphine-induced place preference. Pharmacol Biochem Behav. 1996; 53: 1013-1015.
35. Afanas'ev I, Ferger B, Kuschinsky K. The associative type of sensitization to d-amphetamine is expressed as an NO-dependent dramatic increase in extracellular dopamine in the nucleus accumbens. Naunyn Schmiedebergs Arch Pharmacol. 2000; 362: 232-237.
36. Gracy KN, Pickel VM. Ultrastructural localization and comparative distribution of nitric oxide synthase and N-methyl-D-aspartate receptors in the shell of the rat nucleus accumbens. Brain Res. 1997; 747: 259-272.
37. Zarrindast MR, Faraji N, Rostami P, Sahraei H, Ghoshouni H. Cross-tolerance between morphine- and nicotine-induced conditioned place preference in mice. Pharmacol Biochem Behav. 2003; 74: 363-369.
38. Skoubis PD, Matthes HW, Walwyn WM, Kieffer BL, Maidment NT. Naloxone fails to produce conditioned place aversion in mu-opioid receptor knock-out mice. Neuroscience. 2001; 106: 757-763.
39. Beninger RJ, Miller R Dopamine D1-like receptors and reward-related incentive learning. Neurosci Biobehav Rev. 1998; 22: 335-345.
40. Hoffman DC, Beninger RJ. Selective D1 and D2 dopamine agonists produce opposing effects in place conditioning but not in conditioned taste aversion learning. Pharmacol Biochem Behav. 1988; 31: 1-8.
41. White NM, Packard MG, Hiroi N Place conditioning with dopamine D1 and D2 agonists injected peripherally or into nucleus accumbens. Psychopharmacology (Berl). 1991; 103: 271-276.
42. Rodriguez De Fonseca F, Rubio P, Martin-Calderon JL, Caine SB, Koob GF, Navarro M. The dopamine receptor agonist 7-OH-DPAT modulates the acquisition and expression of morphine-induced place preference. Eur J Pharmacol. 1995; 274: 47-55.
43. Kivastik T, Vuorikallas K, Piepponen TP, Zharkovsky A, Ahtee L. Morphine- and cocaine-induced conditioned place preference: effects of quinpirole and preclamol. Pharmacol Biochem Behav. 1996; 54: 371-375.
44. Biondo AM, Clements RL, Hayes DJ, Eshpeter B, Greenshaw AJ. NMDA or AMPA/kainate receptor blockade prevents acquisition of conditioned place preference induced by D(2/3) dopamine receptor stimulation in rats. Psychopharmacology (Berl). 2005; 179: 189-197.
45. Kling-Petersen T, Ljung E, Wollter L, Svensson K. Effects of dopamine D3 preferring compounds on conditioned place preference and intracranial self-stimulation in the rat J Neural Transm Gen Sect. 1995; 101: 27-39.
46. Mallet PE, Beninger RJ. 7-OH-DPAT produces place conditioning in rats. Eur J Pharmacol. 1994; 261: R5-R6.
47. Khroyan TV, Baker DA, Neisewander JL. Dose-dependent effects of the D3-preferring agonist 7-OH-DPAT on motor behaviors and place conditioning. Psychopharmacology (Berl). 1995; 122: 351-357.
48. Gyertyan I, Gal K. Dopamine D3 receptor ligands show place conditioning effect but do not influence cocaine-induced place preference. Neuroreport. 2003; 14: 93-98.
49. Spyraki C, Fibiger HC. A role for the mesolimbic dopamine system in the reinforcing properties of diazepam Psychopharmacology (Berl). 1988; 94: 133-137.
50. Wu WR, Zhu XZ. The amphetamine-like reinforcing effect and mechanism of L-deprenyl on conditioned place preference in mice. Eur J Pharmacol. 1999; 364: 1-6.